Home > Healthcare > Pharmaceuticals > Finished Drug Form > Infectious Enteritis Treatment Market
Infectious Enteritis Treatment Market size was valued at USD 434.8 million in 2023 and is estimated to grow at 6.3% CAGR from 2024 to 2032. The market has seen notable expansion, largely propelled by the rising incidence of infectious diseases globally. Factors such as contaminated food and water sources, as well as insufficient sanitation, play a role in the transmission of enteric pathogens.
For instance, World Health Organization (WHO) reported that each year unsafe food causes 600 million cases of foodborne diseases and 420,000 deaths globally. Therefore, the increasing prevalence of foodborne illnesses leading to gastrointestinal disorders, including enteritis, contributes to an increasing demand for treatment, thereby driving market growth.
Infectious enteritis treatment refers to the medical interventions aimed at managing and alleviating symptoms associated with enteritis, an inflammation of the small intestine typically caused by infectious agents such as bacteria, viruses, or parasites. Treatment strategies may include antibiotics, antiviral drugs, fluid and electrolyte replacement therapy, dietary modifications, and supportive care to relieve symptoms and promote recovery from the infection.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Infectious Enteritis Treatment Market Size in 2023: | USD 434.8 Million |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 6.3% |
2032 Value Projection: | USD 740.5 Million |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 170 |
Tables, Charts & Figures: | 283 |
Segments covered: | Drug Type, Route of Administration, Medication Type, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|